Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma (Q39399033)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 February 2012

edit

Language	Label	Description	Also known as
English	Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma	scientific article published on 21 February 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

title

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

author

Fumihiro Tanaka

series ordinal

12

object named as

Fumihiro Tanaka

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

author name string

Yoshie Yoshikawa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Ayuko Sato

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Tohru Tsujimura

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Mitsuru Emi

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Tomonori Morinaga

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Kazuya Fukuoka

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Shusai Yamada

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Aki Murakami

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Nobuyuki Kondo

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Seiji Matsumoto

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Yoshitomo Okumura

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Seiki Hasegawa

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Takashi Nakano

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

Tomoko Hashimoto-Tamaoki

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

publication date

21 February 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

published in

Cancer Science

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

volume

103

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

page(s)

868-874

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

cites work

Survival and Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Study of 314 patients in the West Part of Japan

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Multimodality approach in management of malignant pleural mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Frequent mutation of BAP1 in metastasizing uveal melanomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Germline mutations in BAP1 predispose to melanocytic tumors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Germline BAP1 mutations predispose to malignant mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

retrieved

21 January 2018

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latency of asbestos disease among insulation workers in the United States and Canada

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Codeletion of p15 and p16 in primary malignant mesothelioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22321046

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1349-7006.2012.02223.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

PubMed publication ID

22321046

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22321046

retrieved

11 September 2017

ResearchGate publication ID

221819640

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39399033&oldid=1825859548"